Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis

Journal of Critical Care

Volumn 29, Issue 4, 2014, Pages 562-567

  Vianello, Andrea ^a   Arcaro, Giovanna ^a   Battistella, Laura ^a   Pipitone, Emanuela ^b   Vio, Stefania ^c   Concas, Alessandra ^a   Paladini, Luciana ^a   Gallan, Federico ^a   Marchi, Maria Rita ^a   Tona, Francesco ^c   Iliceto, Sabino ^c  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Acute respiratory failure; Idiopathic Pulmonary Fibrosis; Noninvasive Ventilation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; OXYGEN;

ACUTE RESPIRATORY FAILURE; AGED; ARTICLE; BREATHING RATE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; FEMALE; FIBROSING ALVEOLITIS; FLUID THERAPY; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MECHANICAL VENTILATOR; MORTALITY; NONINVASIVE VENTILATION; OBSERVATIONAL STUDY; OXYGEN THERAPY; PORTABLE EQUIPMENT; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; ARTIFICIAL VENTILATION; COMPLICATION; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; SURVIVAL; UTILIZATION;

AGED; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; MALE; NONINVASIVE VENTILATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; RESPIRATORY RATE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84902281901     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.03.019     Document Type: Article

References (36)

1. Christie J.D., Edwards L.B., Kucheryavaya A.Y., Benden C., Dobbels F., Kirk R., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant 2010, 29:1104-1118.
2. Wells A.U., du Bois R.M. Prediction of disease progression in idiopathic pulmonary fibrosis. Eur Respir J 1994, 7:637-639.
3. Hubbard R., Johnston I., Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 1998, 113:396-400.
4. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980, 35:171-180.
5. Ryu J.H., Colby T.V., Hartman T.E. Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc 1998, 73:1085-1101.
6. Azuma A., Nukiwa T., Tsuboi E., Suga M., Abe S., Nakata K., et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005, 171:1040-1047.
7. Collard H.R., Moore B.B., Flaherty K.R., Brown K.K., Kaner R.J., King T.E., et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007, 176:636-643.
8. Agarwal R., Jindal S.K. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur J Intern Med 2008, 19:227-235.
9. Richeldi L., Costabel U., Selman M., Kim D.S., Hansell D.M., Nicholson A.G., et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011, 365:1079-1087.
10. Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
11. Blivet S., Philit F., Sab J.M., Langevin B., Paret M., Guerin C., et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001, 120:209-212.
12. Fumeaux T., Rothmeier C., Jolliet P. Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. Intensive Care Med 2001, 27:1868-1874.
13. Saydain G., Islam A., Afessa B., Scott R.J.P., Peters S.G. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 2002, 166:839-842.
14. Al-Hameed F.M., Sharma S. Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can Respir J 2004, 11:117-122.
15. Mollica C., Paone G., Conti V., Ceccarelli D., Schmid G., Mattia P., et al. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration 2010, 79:209-215.
16. Mallick S. Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 2008, 102:1355-1359.
17. Tomii K., Tachikawa R., Chin K., Murase K., Handa T., Mishima M., et al. Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Intern Med 2010, 49:1341-1347.
18. Yokoyama T., Kondoh Y., Taniguchi H., Kataoka K., Kato K., Nishiyama O., et al. Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 2010, 49:1509-1514.
19. Gungor G., Tatar D., Salturk C., Cimen P., Karakurt Z., Kirakli C., et al. Why do patients with interstitial lung diseases fail in the ICU? A 2-center cohort study. Respir Care 2013, 58:525-531.
20. Ley B., Ryerson C.J., Vittinghoff E., Ryu J.H., Tomassetti S., Lee J.S., et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012, 156:684-691.
21. Best A.C., Meng J., Lynch A.M., Bozic C.M., Miller D., Grunwald G.K., et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology 2008, 246:935-940.
22. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
23. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72.
24. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
25. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
26. American Thoracic Society, European Respiratory Society, European Society of Intensive Care Medicine, Societè de Reanimation de Langue Francaise International Consensus Conference in Intensive Care Medicine: noninvasive positive pressure ventilation in acute respiratory failure. Approved by the ATS Board of Directors, December 2000. Am J Respir Crit Care Med 2001, 163:283-291.
27. Hirji K.F., Mehta C.R., Patel N.R. Computing distributions for exact logistic regression. JASA 1987, 82:1110-1117.
28. Nava S., Hill N. Non-invasive ventilation in acute respiratory failure. Lancet 2009, 374(9685):250-259.
29. Williams T.J., Wilson J.W. Challenges in pulmonary fibrosis: 7 novel therapies and lung transplantation. Thorax 2008, 63:277-284.
30. Hilbert G., Gruson D., Vargas F., Valentino R., Gbikpi-Benissan G., Dupon M., et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001, 344:481-487.
31. Omland T., Hagve T.A. Natriuretic peptides: physiologic and analytic considerations. Heart Fail Clin 2009, 5:471-487.
32. Yap L.B., Mukerjee D., Timms P.M., Ashrafian H., Coghlan J.G. Natriuretic peptides, respiratory disease, and the right heart. Chest 2004, 126:1330-1336.
33. Reesink H.J., Tulevski I.I., Marcus J.T., Boomsma F., Kloek J.J., Vonk N.A., et al. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2007, 84:537-543.
34. Høiseth A.D., Omland T., Hagve T.-H., Brekke P.H., Søyseth V. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD-a prospective cohort study. Respir Res 2012, 13:97.
35. Song J.W., Song J.K., Kim D.S. Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med 2009, 103:180-186.
36. Fernandez-Perez E.R., Ylmaz M., Jenad H., Daniels C.E., Ryu J.H., Hubmayr R.D., et al. Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 2008, 133:1113-1119.